Novel Therapeutics in Atopic Dermatitis
Atopic dermatitis (AD) is a chronic inflammatory skin disease. The pathogenesis of AD is complex with many mediators involved and can be broken down into 4 categories:
Immune dysregulation
Abnormal skin barrier
Abnormal itch/scratch cycle
Abnormal skin microbiome
In AD, there is a breakdown in molecular control of the immune system, leading to overproduction and expressi …
Atopic dermatitis (AD) is a chronic inflammatory skin disease. The pathogenesis of AD is complex with many mediators involved and can be broken down into 4 categories:
Immune dysregulation
Abnormal skin barrier
Abnormal itch/scratch cycle
Abnormal skin microbiome
In AD, there is a breakdown in molecular control of the immune system, leading to overproduction and expressi … 
This month’s Patient Buzz includes articles ranging from K-beauty trends, which are skincare products and practices popular in Korea, to differentiating psoriasis from eczema.
Review this list of dermatology articles from the consumer press and be ready for your patient’s questions about K-beauty and other skin, hair, and nail trends:
Allure: How to prepare for a teledermatology … 
This month’s Patient Buzz includes articles discussing a variety of topics such as itchy, raised tattoos (is this normal?), blue light protection skincare, and other topics uniquely related to the COVID-19 pandemic. Is COVID-19 to blame for eczema flares? Is makeup gone unused in the pandemic still safe to use? Is blue light from extra screen time during the pandemic damaging our skin? What are … 
Dr. Friedman, jack of many trades, Professor and Interim Chair of Dermatology at George Washington University provided an excellent overview of ways to achieve victory over atopic dermatitis (AD). This expert discussion took place during the ODAC Inflammatory Diseases Symposium on December 3, 2020.
How could we possibly cover atopic dermatitis in 20 minutes? Well, Dr. Friedman skillfully led us … 
CASE REPORT
A 71-year-old Fitzpatrick phototype IV man with a history of hyperlipidemia and extensive travel to the Middle East presented with a mildly painful vegetative growth on his right lower leg for 1.5 months (Figure 1). In 2014, the patient reported a pruritic “rash” in the same location, which was treated with fluocinonide .05% ointment with resolution.
[caption id="attachment …